We're available 24/7. Call us anytime. (888) 552-6760
(888) 552-6760 SCHEDULE AN APPOINTMENT

John Baird,

Hematologist-Oncologist

Biography photo
Location
Duarte Comprehensive Cancer Center
1500 East Duarte Road
Duarte, CA 91010
Specialties
Hematologic Oncology
Education
Medical school:
Board Certifications

  • Hematology

  • Medical Oncology

  • Internal Medicine

Degrees

  • 2013, M.D., University of Arkansas for Medical Sciences, Little Rock, AR

  • 2008, B.S., Biomedical Engineering, Washington University, St. Louis, MO

Fellowship

  • 2020-2021, Fellow, Blood and Marrow Transplantation, Stanford Hospital & Clinics, Palo Alto, CA

  • 2019-2020, Postdoctoral Fellow, Cancer Cellular Therapies, Stanford University, Palo Alto, CA

  • 2016-2019, Fellow, Hematology and Medical Oncology, Stanford Hospital & Clinics, Palo Alto, CA

Residency

  • 2014-2016, Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA

Internship

  • 2013-2014, Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA

Professional Experience

  • 2021-Present, Assistant Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Academic Appointments
  • Assistant Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation
About Me
John H. Baird, M.D., was drawn to his career as a doctor when he found working with patients to be his favorite part of his initial focus in biomedical engineering. For him, being a physician-researcher is the best of both worlds. He provides innovative therapies and his own brand of compassionate care to people with leukemia and lymphoma, while also advancing the state of the field in cancer treatment and improving patient outcomes with clinical research.
 
Dr. Baird pursued his medical training at the University of Arkansas, then served as an intern and resident at the University of Pennsylvania and a fellow at Stanford University, where he specialized in medical oncology, hematology, and blood and marrow transplantation. His research concerns next-generation cellular therapies for blood diseases, including CAR T cell therapy, in which a patient's own immune cells are engineered to seek and destroy cancer.
Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.